Angiotensin II for the Treatment of COVID-19-Related Vasodilatory Shock

Anesth Analg. 2020 Jul;131(1):102-105. doi: 10.1213/ANE.0000000000004825.

Authors

Jonathan H Chow¹, Michael A Mazzeffi¹, Michael T McCurdy²

Affiliations

¹ From the Departments of Anesthesiology.
² Medicine and Emergency Medicine, University of Maryland School of Medicine, Baltimore, Maryland.

No abstract available

MeSH terms

Angiotensin II / therapeutic use*
COVID-19
Coronavirus Infections / complications*
Coronavirus Infections / physiopathology
Coronavirus Infections / therapy
Humans
Pandemics
Pneumonia, Viral / complications*
Pneumonia, Viral / physiopathology
Pneumonia, Viral / therapy
Shock / etiology*
Shock / physiopathology
Shock / therapy*
Vasoconstrictor Agents / therapeutic use*

Substances

Vasoconstrictor Agents
Angiotensin II